OQS
PRPH

Occudo Quantitative Strategies’s ProPhase Labs PRPH Stock Holding History

Occudo Quantitative Strategies’s Portfolio PRPH Stock Details PRPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,312
Closed -$95.2K – 1242
2023
Q2 		$95.2K Buy
+1,312
New +$107K 0.01% 925
2022
Q4 		– Sell
-1,116
Closed -$126K – 1288
2022
Q3 		$126K Buy
+1,116
New +$130K 0.01% 1016

Other funds holding PRPH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SW
SVB Wealth Boston, Massachusetts $1.59B AUM 24.57% 1-Year Est. Return

Occudo Quantitative Strategies's PRPH Position: Q3 2023 in Review

Occudo Quantitative Strategies sold out of ProPhase Labs (PRPH) in Q3 2023, closing a stake of 1,312 shares — an estimated $95.2K sold.

Occudo Quantitative Strategies first reported a position in PRPH in Q3 2022 and held it in 2 quarters. The position peaked at $126K in Q3 2022. 35 funds tracked by Wall St. Rank hold PRPH as of Q3 2023.

  • Occudo Quantitative Strategies reported no remaining ProPhase Labs position as of Q3 2023 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 1,312 ProPhase Labs shares in Q3 2023, an estimated $95.2K.
  • Occudo Quantitative Strategies first reported a position in ProPhase Labs in Q3 2022 and held it in 2 quarters.
  • Occudo Quantitative Strategies's ProPhase Labs position peaked at $126K in Q3 2022.
  • 35 funds tracked by Wall St. Rank held ProPhase Labs as of Q3 2023.

Based on Occudo Quantitative Strategies's 13F filing for Q3 2023, filed 14 Nov 2023.